We propose that the expression of STAT2, as well as WEE1, is more robust as prognostic factors for earlier recurrence and/or distant metastasis in younger NSCLC patients than in older NSCLC; this hypothesis remains to be examined in future work. This evidence concerns the gene WEE1 and non-small cell lung carcinoma.